Capula Management LTD Vertex Pharmaceuticals Inc Call Options Transaction History

Capula Management LTD

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$460.0 - $505.78 $138,000 - $151,734	300 New	300 $139,000
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $11.5 Million - $12.9 Million	-40,100 Reduced 79.88%	10,100 $2.92 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $13.7 Million - $15.3 Million	50,200 New	50,200 $14.5 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $2.01 Million - $2.63 Million	8,900 New	8,900 $2.58 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $8.83 Million - $11 Million	-44,200 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $7.35 Million - $8.27 Million	44,200 New	44,200 $7.49 Million

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

Stay updated on Capula Management LTD with notifications on news.